Kronik pelvik ağrı sendromu/tip 3 prostatitli infertil hastaların serum ve ejakülat inhibin B seviyelerinin değerlendirilmesi

AMAÇ: Spermatogenezin hormonal düzenlenmesi son derece önemli olup inhibin B gibi Sertoli hücrelerinin etkinliğini yansıtan peptidlerin seviyesi özelikle önem arzetmektedir. Follikül uyarıcı hormon (FSH) ile karşılaştırıldığında inhibin B’nin erkek fertilite bozukluğunu ortaya koymada daha erken bir endokrin belirteç olduğu gösterilmiştir. Bu çalışmanın amacı kronik pelvik ağrı sendromu/tip 3 kronik prostatitli infertile olgular ile sağlıklı erkek olgularda ejekülat ve surumdaki inhibin B seviyelerinin araştırılmasıdır. GEREÇ VE YÖNTEM: Bu çalışmada yaşları 22–45 yıl arasında olan KPAS/ tip 3 kronik prostatit tanılı 136 olgu değerlendirilmiştir. Bütün hastalar iki gruba ayrılmışlardır. Birinci grup KPAS/Tip 3A kronik prostatitli 96 hastayı içermiştir. İkinci grup ise KPAS/Tip 3B tanılı 40 hastayı içermiştir. Kontrol grubu ise yaş eşleştirilmiş 20 fertil erkekten oluşmuştur. BULGULAR: Bu çalışmanın sonuçları KPAS’lı olgularda inhibin B’nin serum seviyelerinin fertili gruba göre (307,7±81,5 pg/mL), anlamlı olarak daha düşük seviyelerde (105±27,9 pg/mL) olduğunu göstermiştir (p0,05). Benzer sonuçlar sperm konsantrasyonu ve inhibin B seviyeleri sözkonusu olduğunda KPAS ve sağlıklı kontrol grubu arasında saptanmıştır (KPAS’ta 96,1±30,9 pg/mL, sağlıklı kontrol grubunda 303,5±75,4 pg/mL, p

The evaluation of serum and ejaculate inhibin B levels in infertile patients with chronic pelvic pain syndrome/type 3 prostatitis

OBJEKTIVE: The study of the hormonal regulation of spermatogenesis is important, in particular, the level of peptides that directly reflect the Sertoli’s cells activity, which include inhibin B. It demonstrates that in comparison with FSH, inhibin B has been shown to be an earlier endocrine marker of fertility disorder. The aim of our research was to study the inhibin B content in the blood serum and ejaculate of healthy men and men from infertile couples suffering from chronic pelvic pain syndrome/Type 3 prostatitis (CPPS/Type 3 prostatitis). MATERIAL AND METHODS: We examined 136 infertile patients with CPPS at the age of 22–45 years old. All patients were divided into 2 groups. The 1st group included 96 patients with CPPS/Type 3A category. The 2nd group included 40 patients with CPPS/Type 3B. The control group consisted of 20 healthy fertile men, equitable in age. RESULTS: The results of our research indicate that the level of inhibin B in the blood serum in the general group of patients with CPPS, amounting to 105±27.9 pg/mL, was significantly lower compared to fertile men (307.7±81.5 pg/mL, p0.05). Similar data were obtained with respect to the concentration of sperm inhibin B, the level of which among infertile men with CPPS, amounting to 96.1±30.9 pg/mL, was significantly lower in comparison with the group of healthy men (303.5±75.4 pg/mL, p

___

  • 1. Jungwirth A, Diemer T, Kopa Z, Krausz C, Minhas S, Tournaye H. E. A. U. Guidelines on Male Infertility. 2018;6–7. https://uroweb.org/wp-content/ uploads/EAU-Guidelines-on-Male-Infertility-2018-large-text.pdf
  • 2. Hill JA, Cohen J, Anderson DJ. The effects of lymphokines and monokines on human sperm fertilizing ability in the zonafree hamster egg penetration test. Am J Obstet Gynecol 1989;160:1154–9. [CrossRef ]
  • 3. Barratt CLR, Bolton AE, Cooke ID. Functional significance of white blood cells in the male and female reproductive tract. Hum Reprod 1990;5:639–48. [CrossRef ]
  • 4. Krausz C, Mills C, Rogers S, Tan SL, Aitken RJ. Stimulation of oxidant generation by human sperm suspensions using phorbol ester and formly peptides: relationships with motility and fertilization in vitro. Fertil Steril 1994;62:599–05. [CrossRef ]
  • 5. Aşçı R. Subfertil erkeğin değerlendirilmesi. İçinde: Aşçı R, Çayan S, Erdemir F, Orhan İ, Yaman Ö, Usta MF, Kendirci M, Ekmekçioğlu O, Kadıoğlu A, editörler. Erkek Üreme Sistemi Hastalıkları ve Tedavisi. Istanbul Tıp Kitabevi 2013. s.199–215.
  • 6. Chong YH, Pankhurst MW, McLennan IS. The Daily Profiles of Circulating AMH and INSL3 in Men are Distinct from the Other Testicular Hormones, Inhibin B and Testosterone. PLoS One 2015;10:e0133637. [CrossRef ]
  • 7. Anawalt BD, Bebb RA, Matsumoto AM, Groome NP, Illingworth PJ, McNeilly AS, Bremner WJ. Serum inhibin level reflect Sertoli’s cells function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996;81:3341–5. [CrossRef ]
  • 8. Anderson RA, Sharpe RM. Regulation of inhibin production in the human male and its clinical applications. Int J Androl 2000;23:136–44. [CrossRef ]
  • 9. Krause W, Bohring C. Inhibin B as a marker of spermatogenesis. A new dimension in andrology. Hautarzt 2002;53:5–10. [CrossRef ]
  • 10. Anderson A-M, Muller J, Skakkebaek NE. Different roles of prepubertal and postpubertal germ cells and Sertoli cells in the regulation of serum inhibin B levels. J Clin Endocrinol Metab 1998;83:4451–8. [CrossRef ]
  • 11. Datta A, Nayini K, Eapen A. Serum inhibin-B may predict successful sperm retrieval in azoospermic men with normal gonadotropin and testosterone levels. Hum Reprod 2012;27.
  • 12. Nickel JC, Nigro M, Valiquette L, Anderson P, Patrick A, Mahoney J, et al. Diagnosis and treatment of prostatitis in Canada. Urology 1998;52:797– 802. [CrossRef ]
  • 13. Wosnitzer M, Goldstein M, Hardy MP. Review of Azoospermia. Spermatogenesis 2014;4:e28218. [CrossRef ]
  • 14. Calogero AE, Gullo G, La Vignera S, Condorelli RA, Vaiarelli A. Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective doubleblind randomized placebo-controlled study. Andrology 2015;3:491–5. [CrossRef ]
  • 15. Grunewald S, Glander HJ, Paasch U, Kratzsch J. Age-dependent inhibin B concentration in relation to FSH and semen sample qualities: A study in 2448 men. Reproduction 2013;145:237–44. [CrossRef ]
  • 16. Frydelund-Larsen L, Krausz C, Leffers H, Andersson AM, Carlsen E, Bangsboell S, et al. Inhibin B: a marker for the functional state of the seminiferous epithelium in patients with azoospermia factor C microdeletions. J Clin Endocrinol Metab 2002;87:5618–24. [CrossRef ]
  • 17. Jensen TK, Andersson AM, Hjollund NH, Scheike T, Kolstad H, Giwercman A, et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab 1997;82:4059–63. [CrossRef ]
  • 18. Yalti S, Gürbüz B, Fiçicioglu C. Serum levels of inhibin B in men and their relationship with gonadal hormones, testicular volume, testicular biopsy results and sperm parameters. J Obstet Gynaecol 2002;22:649– 54. [CrossRef ]
  • 19. Barbotin AL, Ballot C, Sigala J, Ramdane N, Duhamel A, Marcelli F, Rigot JM, Dewailly D, Pigny P, Mitchell V. The serum inhibin B concentration and reference ranges in normozoospermia. Eur J Endocrinol 2015;172:669–76. [CrossRef ]
  • 20. Ruiz Plazas X, Burgues Gasion JP, Ozonas Moragues M, Piza Reus P. Utility of inhibin B in the management of male infertility. Actas Urol Esp 2010;34:781–7. https://pubmed.ncbi.nlm.nih.gov/20843455/
  • 21. Manzoor SM, Sattar A, Hashim R, Farooq Ahmad Khan, Muhammad Younas, Asif Ali, et al. Serum inhibin B as a diagnostic marker of male infertility. J Ayub Med Coll Abbottabad 2012;24:113–6. https:// pubmed.ncbi.nlm.nih.gov/24669628/
  • 22. Baker K, Sabanegh E Jr. Obstructive azoospermia: reconstructive techniques and results. Clinics (Sao Paulo) 2013;68:61–73. [CrossRef ]
  • 23. Chong YH, Pankhurst MW, McLennan IS. The Daily Profiles of Circulating AMH and INSL3 in Men are Distinct from the Other Testicular Hormones, Inhibin B and Testosterone. PLoS One 2015;10:e0133637. [CrossRef ]
  • 24. Dong ZY, Zhang RL, He ZX, Sun HC. Relationship between pathological alterations of spermatogenic impairment and serum inhibin B concentration in patients with azoospermia. Zhonghua Nan Ke Xue 2006;12:18–20, 24.
  • 25. Brugo-Olmedo S, De Vincentiis S, Calamera JC, Urrutia F, Nodar F, Acosta AA. Serum inhibin B may be a reliable marker of the presence of testicular spermatozoa in patients with nonobstructive azoospermia. Fertil Steril 2001;76:1124–9. [CrossRef ]
  • 26. Klingmüller D, Haidl G. Inhibin-B in men with normal and disturbed spermatogenesis. Hum Reprod 1997;12:2376–8. [CrossRef ]
  • 27. llingworth PJ, Groome NP, Byrd W, Rainey WE, McNeilly AS, Mather JP, Bremner WJ. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996;81:1321–5. [CrossRef ]
  • 28. Erdemir F, Parlaktaş BS, Uluocak N. Prostatitlerin Patofizyolojisi, Tanısı, Tedavisi ve Değerlendirilmesindeki Yenilikler. Üroloji Bült 2007;18:147–55.
  • 29. Li HJ, Xu P, Liu JS et al. Prevalence of chronic prostatitis and its effects on male infertility. Zhonghua Yi Xue Za Zhi 2004;84:369–71. https:// europepmc.org/article/med/15061985
  • 30. Nicolas N, Michel V, Bhushan S, Wahle E, Hayward S, Ludlow H, et al. Testicular activin and follistatin levels are elevated during the course of experimental autoimmune epididymo-orchitis in mice. Sci Rep 2017;7:42391. [CrossRef ]